Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy

Storrar,Neill

Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy - 2017

Serial 7124479 130 1 https://doi.org/10.1182/blood.V130.Suppl_1.1872.1872 Document_7124479_27363.pdf

00064971
London Health Libraries Koha Consortium privacy notice